On November 10th RIWI Q3 2020 financials were released. Right off the bat, it was a disappointing quarter. Revenue was down compared to Q3 2019 and down consecutively compared to…
Welcome to my Q3 2020 portfolio update. 2020 has been a wild ride. My portfolio greatly rebounded from the depths it reached in Q1 and Q2. I've learned if you…
On September 24th NamSys Q3 2020 results were released. NamSys continues to grow in a tough economic environment. Revenue increased 11.8% in Q3 and 16.6% in the past nine months.…
On August 20th, CO2 Gro Q2 2020 results were released. There isn't a ton of information to be gathered from the financials. Cash on the balance sheet at the end…
On August 11th Crescita Q2 2020 financials were released. It was a difficult quarter for Crescita. In March Crescita closed its office and manufacturing facility in Quebec. Not only was…
On July 27th RIWI Q2 2020 financials were released. The quarter was good but not spectacular. RIWI generated $1 million in revenue and $117,000 in net income. The numbers look…
Crescita Therapeutics is now a net-net stock. With their recent announcement of a one time payment from Taro for $5.2 million Crescita is trading at less that its net-current-asset-value. On…
Welcome to my Q2 2020 portfolio update. I still don't have a set format for these updates. For this update I'll give one or two lines on each position and…
On June 24th, 2020, NamSys Q2 2020 results were released. The company continues to show growth in a challenging COVID-19 environment. Revenue was up 14.5% for Q2 and up 19.2%…
After reviewing Brinks Q1 2020 conference call transcript I realized that Brinks is launching Cirreon Banking under their Brinks Complete solution. Brinks is in the midst of launching Strategy 2.0.…